Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STS101 in acute migraine
NCT03901482Phase 3Completed
- Start
- Jun 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dihydroergotamine in migraine. Started Jun 2019; status: completed.
02
Drugs
dihydroergotamine
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03901482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03901482.